
Carcinoid tumour comes into the category of cancer types that grow slowly and develop in the body's neuroendocrine cells in several organs, including the lungs, gastrointestinal tract, and rectum. These tumours are broader neuroendocrine tumours (NET).
Causes
Risk Factors
To control symptoms and stop tumor growth, somatostatin analogs are used in Malaysia to treat carcinoid tumors. Advanced instances are also being treated with targeted medicines like Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium-177-DOTATATE. Clinical trials are actively conducted by Malaysian healthcare institutes, giving access to new treatments and advancing international research on neuroendocrine tumors.
The medical treatment for Carcinoid Tumors requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgery: It is the primary treatment option for localised carcinoid tumours, and the tumour must be surgically excised. If the tumour reaches the liver, liver resection may be performed to eliminate affected parts.
Analogue Treatment: Treatments that control symptoms of carcinoid syndrome (flushing, diarrhoea) by inhibiting hormone production by the tumour and thus improving the quality of life.
Targeted therapy : These medications slow tumour growth in patients suffering from advanced carcinoids. These therapies block specific signals that stimulate tumour growth and can be applied to metastasis cases.
Cost Start From USD 2000 - USD 10000Explore Options
Chemotherapy and Radiotherapy: Advanced or metastatic carcinoid tumours are treated by chemotherapy; however, this treatment is less effective. PRRT and external radiation are sources of radiation that target tumours, most especially those in the liver.
Cost Start From USD 1500 - USD 3500Explore Options
Liver-directed therapies include radiofrequency ablation and SIRT, which address hepatic metastasis. Palliative care, such as effective pain relief and symptom control for carcinoid syndrome, is also essential for the quality of life.
These are the standard diagnostic methods for diagnosing Carcinoid Tumor:
Blood tests:
Biopsy:
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions. These services include:
Depending on the situation, your healthcare professional may prescribe medicine to help control your symptoms and support the treatment plan.









Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.

Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the rapidly growing reasons for Malaysia being frequented for Carcinoid Tumor treatment:
Carcinoid tumours are classified as a form of cancer, although they develop slowly at times and stay asymptomatic for years. Some may extend to other body parts (like the liver and the lungs), although, in general, they have better survival chances than other cancer types that are more serious.
Carcinoid tumors can recur after their operation or treatment, especially when it has undergone metastasis. Thus, follow-up visits and imaging scans must regularly be given to observe and check for recurrence.
Carcinoid syndrome present symptoms such as flushing, diarrhoea, wheezing, and symptoms involving the heart due to the production of hormones, mainly serotonin, by carcinoid tumours. The syndrome is more prevalent in metastatic carcinoid tumours and those with liver metastasis.
Prognosis varies by location, stage, and whether it has spread to other organs in carcinoid tumour patients. Localised, early-stage tumours usually have good prognoses, but ongoing treatment and management may be necessary with metastatic or advanced ones.
Dietary therapy does not cause carcinoid tumours; however, some patients might need nutritional changes to avoid the effects of carcinoid syndrome on experiencing symptoms like diarrhoea or weight loss. However, the proper diet should be well balanced and adjusted to individual needs to maintain health overall.
Several clinical studies are ongoing, concentrating on advancing carcinoid tumour treatments, including newer drugs, therapies, and management approaches for symptoms. Such trials are available for participation by patients who meet the requirements.
Similar to worldwide trends, carcinoid tumours are comparatively uncommon in Malaysia; nonetheless, advances in diagnostic methods lead to increased detection. Better treatment outcomes and earlier diagnosis have resulted from increased awareness and screening.
Tumor location, stage, and treatment all affect the survival rate of carcinoid tumours in Malaysia. While advanced instances have a reduced survival probability, early-stage carcinoid tumors often have a high five-year survival rate of over 90%.
Malaysia physicians specialising in treating carcinoid tumours include gastroenterologists, endocrinologists, surgical oncologists, and oncologists. A multidisciplinary team approach guarantees effective illness management, diagnosis, and treatment.
When selecting a hospital in Malaysia to treat carcinoid tumours, look for hospitals with dedicated oncology departments, skilled multidisciplinary teams, and cutting-edge treatment options, including targeted therapy and minimally invasive surgery.
Malaysia is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Yes, Malaysia's healthcare system accepts patients from abroad and provides excellent Carcinoid Tumor treatments at many clinics and hospitals.
Yes, many hospitals in Malaysia offer in-person and online consultations to foreign patients who want a second opinion.You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.